Trials / Completed
CompletedNCT00520754
Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children
The Efficacy and Safety of Levocetirizine Dihydrochloride Oral Drops Given 0.125 mg/kg b.i.d. During 90 Days in the Treatment of Recurrent Cough Associated With Other Allergic Symptoms, e.g. Wheezing, in Children Aged 1-2 Years.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 2 Months – 24 Months
- Healthy volunteers
- Not accepted
Summary
Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levocetirizine dihydrochloride |
Timeline
- Start date
- 2001-12-01
- Primary completion
- 2003-03-01
- Completion
- 2003-03-01
- First posted
- 2007-08-27
- Last updated
- 2013-12-12
Source: ClinicalTrials.gov record NCT00520754. Inclusion in this directory is not an endorsement.